Skip to content

Comparison of pulmonary coation in patients undergoing laparmplicoscopic surgery with deep neuromuscle-blocking protective ventilation and routine ventilation

Comparison of pulmonary coation in patients undergoing laparmplicoscopic surgery with deep neuromuscle-blocking protective ventilation and routine ventilation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019270
Enrollment
Unknown
Registered
2018-11-02
Start date
2018-11-20
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary complications

Interventions

Group 1:Deep neuromuscle-blocking laparoscopic surgery with conventional ventilation
Group 2:Deep neuromuscle-blocking laparoscopic surgery with PLVS

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged at least 65 years old, BMI 18.5-30kg/m2; 2. patients undergoing elective laparoscopic abdominal surgery; 3. estimated mechanical ventilation time is greater than 2 hours; 4. Sign the research informed consent form; 5. SpO2 = 95% when inhaling air.

Exclusion criteria

Exclusion criteria: 1. ASA anesthesia grade = 4; 2. body mass index = 30kg / m2; 3. Within 1 months, there were acute respiratory failure, pneumonia, ALI/ARDS, asthma attack, etc. or a history of mechanical ventilation greater than 1 hour within 2 weeks before surgery; 4. can not communicate before surgery because of coma, severe mental retardation, language or hearing impairment; 5. existing hemodynamic instability, sepsis or septic shock; 6. patients have schizophrenia, epilepsy, Parkinson's disease, progressive neuromuscular diseases such as myasthenia gravis; 7. patients with severe COPD (required assisted ventilation / oxygen therapy / repeated acute attacks requiring systemic hormonal therapy) or patients with pulmonary bullae; 8. severe heart, liver, kidney disease (NYHA = III / suspicious malignant arrhythmia / acute coronary syndrome / uremia / hepatic encephalopathy, etc.); 9. involved in other clinical studies or refused to participate in the research; 10. high blood pressure patients whose blood pressure is not properly controlled; hypoproteinemia; 11. with infection history in past 1 week before surgery.

Design outcomes

Primary

MeasureTime frame
PPCs;

Countries

China

Contacts

Public ContactQingguo Zhang

Department of Anesthesiology, Zhujiang Hospital, Southern Medical University

zjyyzqg@126.com+86 13580586538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026